Publications from the Mesobank team

MesobanK UK: an international mesothelioma bioresource
Rintoul RC, Rassl DM, Gittins J, Marciniak SJ; MesobanK collaborators.
Thorax. 2016 Apr;71(4):380-2. doi: 10.1136/thoraxjnl-2015-207496.

Exploring High Aspect Ratio Gold Nanotubes as Cytosolic Agents: Structural Engineering and Uptake into Mesothelioma Cells.
Ye S, Azad AA, Chambers JE, Beckett AJ, Roach L, Moorcroft SCT, Aslam Z, Prior IA, Markham AF, Coletta PL, Marciniak SJ, Evans SD. Small. 2020 Nov;16(46):e2003793. doi: 10.1002/smll.202003793. Epub 2020 Oct 25. PMID: 33103323.

Use of preclinical models for malignant pleural mesothelioma
Shamseddin M, Obacz J, Garnett MJ, Rintoul RC, Francies HE, Marciniak SJ. Thorax. 2021 Mar 10:thoraxjnl-2020-216602. doi: 10.1136/thoraxjnl-2020-216602. Epub ahead of print. PMID: 33692175.

Biological basis for novel mesothelioma therapies
Obacz J, Yung H, Shamseddin M, Linnane E, Liu X, Azad AA, Rassl DM, Fairen-Jimenez D, Rintoul RC, Nikolić MZ, Marciniak SJ. Biological basis for novel mesothelioma therapies. Br J Cancer. 2021 Jul 5. doi: 10.1038/s41416-021-01462-2. Epub ahead of print. PMID: 34226685.